KPRX - KIORA PHARMACEUTICALS INC

2.65
0.050   1.887%

Share volume: 12,528
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$2.60
0.05
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
38%
Profitability 25%
Dept financing 31%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
N/A
3.525 3.040
-0.485 -13.76%
+ Add row to compare
Performance
5 Days
0.93%
1 Month
-16.93%
3 Months
-24.79%
6 Months
-21.13%
1 Year
-48.34%
2 Year
-91.86%
Key data
Stock price
$2.65
P/E Ratio 
2.75
DAY RANGE
$2.56 - $2.94
EPS 
-$1.91
52 WEEK RANGE
$2.51 - $5.76
52 WEEK CHANGE
-$50.47
MARKET CAP 
9.903 M
YIELD 
N/A
SHARES OUTSTANDING 
2.971 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-09-2025
BETA 
1.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$15,877
AVERAGE 30 VOLUME 
$11,416
Company detail
CEO: Brian M. Strem
Region: US
Website: kiorapharma.com
Employees: 10
IPO year: 2015
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Kiora Pharmaceuticals, Inc. develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases.

Recent news
loading